Qurate’s has announced the addition of the “Prostatic Artery Embolization Market” The report focuses on global major leading industry players with information such as company profiles, product picture and specification.
Expert studies the present scenario (with the base year being 2017) and the growth prospects of global Prostatic Artery Embolization market for 2018-2023.
PAE is a non-surgical way of treating an enlarged and troublesome prostate by blocking off the arteries that feed the gland and making it shrink. It is performed by an interventional radiologist, rather than a surgeon, and is an alternative to a TURP (trans urethral resection of prostate) operation. PAE was first performed in 2009, and since then over 200 men have had the procedure performed predominantly in Portugal and Brazil. University Hospital Southampton has been offering a PAE service from April 2012 and is the first UK centre to perform this procedure.
Over the next five years, Expert projects that Prostatic Artery Embolization will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
Request Free Sample Report@ https://www.qurateresearch.com/report/sample/ICT/QBI-LPI-ICT-58478
This report presents a comprehensive overview, market shares and growth opportunities of Prostatic Artery Embolization market by product type, application, key companies and key regions.
To calculate the market size, Expert considers value generated from the sales of the following segments:
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
UNC Health Care
Tampa General Hospital
This report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/ICT/QBI-LPI-ICT-58478
Segmentation by product type:
Segmentation by application:
Yonger than 60
Older than 85
We can also provide the customized separate regional or country-level reports, for the following regions:
Middle East & Africa
To study and analyze the global Prostatic Artery Embolization market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Prostatic Artery Embolization market by identifying its various subsegments.
Focuses on the key global Prostatic Artery Embolization players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostatic Artery Embolization with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Prostatic Artery Embolization submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.